Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Etrasimod for the Treatment of Active UC in Chinese Adults: A National Multicenter Prospective Registry Study (E-HEAL CHINA)

NCT07705126 is registered in ClinicalTrials.gov with Tang-Du Hospital as lead sponsor.

NCT NCT07705126
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07705126 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Etrasimod for the Treatment of Active UC in Chinese Adults: A National Multicenter Prospective Registry Study (E-HEAL CHINA)
Lead sponsor
Tang-Du Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
July 15, 2026
Completion date
June 30, 2028
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis (uc)